Synonyms:Rilmenidine, 54187-04-1, Oxaminozoline, Hyperium, N-(Dicyclopropylmethyl)-4,5-dihydrooxazol-2-amine, Rilmenidine [INN], N-(Dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine, Rilmenidia [Spanish], Rilmenidinum [Latin], 2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-, CHEBI:8862, Oxazolidine, 2-((dicyclopropylmethyl)imino)-, P67IM25ID8, DTXSID3045194, Rilmenidine (INN), NSC664312, NCGC00015884-09, CAS-54187-04-1, NSC 664312; Oxaminozoline; Rilmenidene;S 3341, DTXCID1025194, SR-01000002992, EINECS 259-021-0, S 3341, BRN 1211287, UNII-P67IM25ID8, Hyperium (TN), Methylamine, 1,1-dicyclopropyl-N-(2-oxazolinyl)-, 2-Oxazolamine, 4,5-dihydro-N-(dicyclopropylmethyl)-, Tocris-0790, ARSENICTRIFLUORIDE, Lopac-R-134, RILMENIDINE [MI], Prestwick0_000982, Prestwick1_000982, Prestwick2_000982, Prestwick3_000982, Lopac0_001104, BSPBio_001043, RILMENIDINE [WHO-DD], SCHEMBL114420, SPBio_002944, BPBio1_001149, CHEMBL289480, HMS2089G15, HMS3263M10, Tox21_110254, Tox21_501104, BDBM50070328, MFCD00865924, 2-(dicyclopropylmethylamino) oxazoline, AKOS006273431, Tox21_110254_1, AB07513, CCG-205180, DB11738, LP01104, NSC-664312, SDCCGSBI-0051073.P002, NCGC00015884-01, NCGC00015884-02, NCGC00015884-03, NCGC00015884-04, NCGC00015884-05, NCGC00015884-06, NCGC00015884-07, NCGC00015884-08, NCGC00015884-10, NCGC00015884-11, NCGC00015884-13, NCGC00015884-19, NCGC00021689-02, NCGC00021689-04, NCGC00021689-05, NCGC00021689-06, NCGC00261789-01, (N-dicyclopropylmethyl)-amino-2-oxazoline, NCI60_022181, SY267932, DB-052512, HY-100490, AB00514648, CS-0019423, EU-0101104, FT-0630668, R-134, D08482, AB00513728-09, EN300-8092697, A830020, L001230, Q967973, N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine;, SR-01000002992-3, SR-01000002992-4, W-105661, N-(dicyclopropylmethyl)-4,5-dihydrooxazol-3-ium-2-amine, N-(Dicyclopropylmethyl)-N-(4,5-dihydro-1,3-oxazol-2-yl)amine
Id:68712
Description:nan
